Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Pharmacokinetics of AMP-579 are affected by body weight but not by renal function

March 24, 1999

Allos presents phase Ib results of RSR-13 in patients with angina

March 24, 1999

Kyowa Hakko and Cor select development candidates for inhibiting PDGF receptor phosphorylation

March 24, 1999

Integrin receptor antagonists disclosed by SB

March 24, 1999

SB-247083: design of a selective, orally active ETA antagonist

March 23, 1999

ABT-627 now being evaluated in humans

March 23, 1999

Endothelin receptor antagonists for cardiovascular, renal and cerebral disorders

March 22, 1999

News from ASCPT: first report of clinical evaluation of Schwarz's organic nitrate

March 22, 1999

Gliatech initiates new R&D program for antiinflammatory MAbs

March 19, 1999

Pharmacological profile of A-216546, a novel endothelin antagonist

March 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...